SG Americas Securities’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-39,889
| Closed | -$2.71M | – | 3544 |
|
|
2019
Q3 | $2.71M | Sell |
39,889
-34,798
| -47% | -$2.39M | 0.02% | 753 |
|
|
2019
Q2 | $4.34M | Buy |
74,687
+71,199
| +2,041% | +$4.22M | 0.03% | 604 |
|
|
2019
Q1 | $244K | Sell |
3,488
-5,456
| -61% | -$405K | ﹤0.01% | 2431 |
|
|
2018
Q4 | $576K | Buy |
8,944
+3,807
| +74% | +$267K | 0.01% | 1764 |
|
|
2018
Q3 | $361K | Buy |
5,137
+1,925
| +60% | +$113K | ﹤0.01% | 2282 |
|
|
2018
Q2 | $162K | Buy |
+3,212
| New | +$127K | ﹤0.01% | 2746 |
|
|
2017
Q4 | – | Sell |
-8,769
| Closed | -$281K | – | 3844 |
|
|
2017
Q3 | $281K | Buy |
8,769
+2,647
| +43% | +$83.5K | ﹤0.01% | 2305 |
|
|
2017
Q2 | $199K | Buy |
6,122
+1,679
| +38% | +$53.2K | ﹤0.01% | 2432 |
|
|
2017
Q1 | $140K | Sell |
4,443
-7,856
| -64% | -$232K | ﹤0.01% | 2716 |
|
|
2016
Q4 | $361K | Buy |
+12,299
| New | +$375K | ﹤0.01% | 1919 |
|
|
2015
Q4 | – | Sell |
-11,302
| Closed | -$239K | – | 3096 |
|
|
2015
Q3 | $239K | Buy |
+11,302
| New | +$291K | ﹤0.01% | 1341 |
|
|
2015
Q1 | – | Sell |
-5,972
| Closed | -$191K | – | 3246 |
|
|
2014
Q4 | $191K | Buy |
+5,972
| New | +$194K | ﹤0.01% | 2454 |
|
|
2014
Q3 | – | Sell |
-4,899
| Closed | -$134K | – | 2925 |
|
|
2014
Q2 | $134K | Buy |
+4,899
| New | +$130K | ﹤0.01% | 2225 |
|
|
2014
Q1 | – | Sell |
-14,960
| Closed | -$438K | – | 2897 |
|
|
2013
Q4 | $438K | Sell |
14,960
-1,792
| -11% | -$56.9K | ﹤0.01% | 1622 |
|
|
2013
Q3 | $512K | Buy |
16,752
+8,088
| +93% | +$270K | ﹤0.01% | 1597 |
|
|
2013
Q2 | $275K | Buy |
+8,664
| New | +$285K | ﹤0.01% | 1561 |
|
SG Americas Securities's GHDX Position: Q4 2019 in Review
SG Americas Securities sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 39,889 shares — an estimated $2.71M sold.
SG Americas Securities first reported a position in GHDX in Q2 2013 and held it in 16 quarters. The position peaked at $4.34M in Q2 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.
- SG Americas Securities reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
- SG Americas Securities sold 39,889 Genomic Health, Inc. shares in Q4 2019, an estimated $2.71M.
- SG Americas Securities first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 16 quarters.
- SG Americas Securities's Genomic Health, Inc. position peaked at $4.34M in Q2 2019.
- 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.
Based on SG Americas Securities's 13F filing for Q4 2019, filed 28 Jan 2020.